Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akitsu Hotta

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2022
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challengesEman A Taha, Joseph Lee, Akitsu Hotta
Methods (San Diego, Calif.)|November 4, 2015
Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 systemHongmei Lisa Li, Peter Gee, Kentaro Ishida, et al.
Cell Reports. Medicine|July 1, 2021
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCsTomoya Uchimura, Toshifumi Asano, Takao Nakata, et al.
Stem Cell Research & Therapy|March 19, 2024
iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressivaPan Gao, Yoshiko Inada, Akitsu Hotta, et al.
STAR Protocols|November 26, 2021
Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cellsHuaigeng Xu, Yuto Kita, Uikyu Bang, et al.
Scientific Reports|January 11, 2023
Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCsRyu Kawada, Tatsuya Jonouchi, Akihiro Kagita, et al.
Stem Cell Reports|August 5, 2022
Direct visualization of the transition status during neural differentiation by dual-fluorescent reporter human pluripotent stem cellsGwanghyun Park, Minkyung Shin, Wonyoung Lee, et al.
Molecular Therapy. Nucleic Acids|June 17, 2026
Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editingYouichi Naoe, Naoko Fujimoto, Yukimasa Makita, et al.
European Journal of Cell Biology|July 26, 2024
Elimination of the extra chromosome of Dup15q syndrome iPSCs for cellular and molecular investigationHaruka Munezane, Keiko Imamura, Naoko Fujimoto, et al.
Stem Cell Research|July 26, 2020
Generation of a transgene-free iPSC line and genetically modified line from a facioscapulohumeral muscular dystrophy type 2 (FSHD2) patient with SMCHD1 p.Lys607Ter mutationMitsuru Sasaki-Honda, Akihiro Kagita, Tatsuya Jonouchi, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2022
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challengesEman A Taha, Joseph Lee, Akitsu Hotta
Methods (San Diego, Calif.)|November 4, 2015
Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 systemHongmei Lisa Li, Peter Gee, Kentaro Ishida, et al.
Cell Reports. Medicine|July 1, 2021
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCsTomoya Uchimura, Toshifumi Asano, Takao Nakata, et al.
Stem Cell Research & Therapy|March 19, 2024
iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressivaPan Gao, Yoshiko Inada, Akitsu Hotta, et al.
STAR Protocols|November 26, 2021
Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cellsHuaigeng Xu, Yuto Kita, Uikyu Bang, et al.
Scientific Reports|January 11, 2023
Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCsRyu Kawada, Tatsuya Jonouchi, Akihiro Kagita, et al.
Stem Cell Reports|August 5, 2022
Direct visualization of the transition status during neural differentiation by dual-fluorescent reporter human pluripotent stem cellsGwanghyun Park, Minkyung Shin, Wonyoung Lee, et al.
Molecular Therapy. Nucleic Acids|June 17, 2026
Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editingYouichi Naoe, Naoko Fujimoto, Yukimasa Makita, et al.
European Journal of Cell Biology|July 26, 2024
Elimination of the extra chromosome of Dup15q syndrome iPSCs for cellular and molecular investigationHaruka Munezane, Keiko Imamura, Naoko Fujimoto, et al.
Stem Cell Research|July 26, 2020
Generation of a transgene-free iPSC line and genetically modified line from a facioscapulohumeral muscular dystrophy type 2 (FSHD2) patient with SMCHD1 p.Lys607Ter mutationMitsuru Sasaki-Honda, Akihiro Kagita, Tatsuya Jonouchi, et al.
Pageof 10